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We propose that renal salvage is possible in neonatal inferior vena cava (IVC) and bilateral renal vein
thrombosis utilizing early surgical intervention. Management of bilateral renal vein thrombosis with
renal impairment typically includes anti-coagulation and thrombolytic therapy. We report a case of a ﬁve
day-old premature female, found to have bilateral renal vein thrombosis that had propagated up the IVC,
associated with anuric renal failure. Peak BUN/creatinine was 52/4 at day of life 5, with a peak of 90/7.4 at
day of life 10. After a failed attempt at intravenous thrombolytic therapy, thrombectomy was performed
for the IVC as well as both renal veins. The patient urinated by post-operative day 2. Function improved
daily, with creatinine stabilizing at 0.4 mg/dL by one month. Serial ultrasounds showed persistent
patency of the IVC and bilateral renal veins. The patient was heterozygous for the Factor V Leiden mu-
tation and pathology demonstrated evidence of placental thrombosis. We have shown that neonatal
anuric renal failure secondary to bilateral renal vein thrombosis can be successfully managed with early
surgical thrombectomy without the need for nephrectomy. Restoration of renal function after surgical
thrombectomy in this patient illustrates the potential reversibility of acute renal failure even in severe
cases.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Neonatal renal vein thrombosis is a rare event that for many
decades went undiagnosed until discovery at operation or post-
mortem. Once recognized as a clinical entity, treatment consisted of
aggressive surgical intervention via nephrectomy [1,2]. During the
1960’s, however, this approach was called into question and many
began advocating the use of anti-coagulation and thrombolytic
therapy [3]. The relatively small number of reported cases and lack
of prospective trials have raised debate regarding the best way to
manage this condition.
The aim of this case report is to demonstrate that renal salvage is
possible in neonatal inferior vena cava (IVC) and bilateral renal vein
thrombosis by utilizing a combined approach of early surgical
intervention and anticoagulation. Although unilateral renal vein
thrombosis is one of the more commonly diagnosed thromboticBY-NC-ND license (http://
ysician’s Ofﬁce Bldg., Chapel
19 843 2497.
gmail.com (S. Lee).
Published by Elsevier Inc. All rightevents in neonates, this case is notable for bilateral involvement
with IVC extension and obstruction, the lack of preceding umbilical
vein catheterization, and the severe degree of renal impairment. To
date, there are no reports of successful surgical thrombectomy
without nephrectomy with recovery of renal function following
bilateral renal vein thrombosis in a neonate.1. Case report
We report the case of a ﬁve day old premature female born at 35
5/7 weeks gestational age with a birth weight of 1.8 kg who was
found to have bilateral renal vein thrombosis with thrombus
propagation up the IVC to the level of the hepatic vein conﬂuence.
The patient initially presented shortly after birth with bilateral
lower extremity swelling and transient duskiness, bilateral ﬂank
masses (left greater than right), and oliguria. Ultrasound exami-
nation demonstrated left renal vein thrombosis which rapidly
progressed to include both renal veins as well as the IVC despite the
institution of systemic anticoagulation (see Fig. 1). The patient was
transferred to our institution on day of life 3 in anuric renal failures reserved.
Fig. 1. Abdominal ultrasound of mid-IVC, demonstrating occlusive thrombosis.
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therapy as the infant was deemed too small for catheter-directed
therapy. Unfortunately, repeat ultrasound after 8 h of therapy
revealed minimal arterial and venous ﬂow in the left kidney and
marginal ﬂow in the right kidney, as well as variable loss of corti-
comedullary differentiation.With ongoing anuric renal failure, poor
to absent blood ﬂow in both kidneys and no evidence of improve-
ment with systemic thrombolytic therapy, the patient was taken to
the operating room for surgical intervention on day of life 5. The
BUN and creatinine at the time of surgery were 52 g/dL and 4 mg/
dL, respectively. Laparotomy by transverse supraumbilical incision
was performed, and exploration revealed that both kidneys were
engorged, blue and ﬁrm, with a signiﬁcant retroperitoneal inﬂam-
matory reaction surrounding them. There was scant perfused pa-
renchyma in the right kidney only. Clot was visible in both renal
veins and the IVC, with a dramatic inﬂammatory reaction around
these vessels. After successful proximal and distal control of the IVC
and both renal veins was obtained, thrombectomy via anterior
cavotomy was performed, with removal of old and fresh blood clot
from all vessels. There was evidence of calciﬁcation in some areas
suggesting that thrombosis was chronic and had begun in utero.
The cavotomy was then closed with 6-0 Prolene and a single-cuff
infant peritoneal dialysis catheter was inserted. Intraoperative
Doppler ultrasound revealed venous ﬂow within the proximal and
distal IVC and in the right renal vein. In addition, there was forward
diastolic arterial ﬂow within the right renal artery, which had not
been there previously. The patient was therapeutically anti-
coagulated with unfractionated heparin in the operating room.
Anticoagulation continued post-operatively with low molecular
weight heparin (Fig. 2).
The patient began making urine by post-operative day 2, with
normalization of urine output volume within one week. Renal
function improved daily after a peak BUN of 90 g/dL and peakFig. 2. Normalization of creatinine ovecreatinine of 7.4 mg/dL on post-operative day 5. By one month after
surgery, the creatinine had stabilized at 0.4 mg/dL. The patient
underwent a laboratory evaluation for thrombophilia, the results of
which indicated she was a heterozygous carrier of the Factor V
Leiden mutation. Pathologic evaluation of the mother’s placenta
was performed, revealing widespread features of placental fetal
vascular thrombosis: recent to old chorionic and stem villous
thrombi, multifocal avascular villi, and villous stromal karyorrhexis.
Marginal umbilical cord insertion, a predisposing condition for cord
compression, was also present.
The peritoneal dialysis catheter was removed on post-operative
day 16, when it was clear that the patient would not require dial-
ysis. The patient was discharged home on post-operative day 30 on
1.5 mg/kg low molecular-weight heparin twice daily. Serial
abdominal ultrasounds showed persistent patency of the IVC and
bilateral renal veins (see Fig. 3). Re-evaluation of the kidneys by
ultrasound at three months revealed signs of left renal atrophy
despite overall preserved renal function. Low molecular-weight
heparin was continued for a total of six months.
2. Discussion
Spontaneous renal vein thrombosis is a predominantly neonatal
disease, with themajority of cases occurringwithin the ﬁrst 30 days
of life [4]. Predisposing physiologic factors include decreased renal
blood ﬂow, hemoconcentration, and a prothrombotic state. Pre-
disposing clinical conditions include preterm delivery, perinatal
asphyxia, polycythemia, congenital heart disease, maternal dia-
betes, congenital nephrotic syndrome, cytomegalovirus infection,
shock, activated protein C resistance (including factor V Leiden
heterozygosity), andmaternal diuretic and steroid exposure [5e13].
Nearly 50% of cases will demonstrate thrombophilia [5,13]. Disease
presentation may be unilateral or bilateral, and in rare cases, mayr time after surgical intervention.
Fig. 3. Post-op abdominal ultrasound of mid-IVC, demonstrating patency.
S. Lee et al. / J Ped Surg Case Reports 2 (2014) 176e179178include extensive inferior vena caval involvement. Overall survival
is excellent, but morbidity can be signiﬁcant, with renal atrophy,
hypertension, and chronic urinary tract infection among the
possible sequelae.
Patients may present in the neonatal period with a palpable
abdominal mass (representing the associated kidney) and gross
hematuria. Most cases are left-sided and unilateral with a male
preponderance [14]. Initial laboratory ﬁndings may include
thrombocytopenia, leukocytosis, varying degrees of renal
dysfunction, and blood and protein on urinalysis. The diagnostic
test is renal ultrasound, which demonstrates thrombus within the
renal vein and renal enlargement [15]. Renal nuclear medicine
scans, CT, and MRI are usually not necessary unless looking for
possible external compression.
Previously, deﬁnitive surgical treatment of renal vein throm-
bosis consisted of nephrectomy and thrombectomy on a nonurgent
basis, provided there was no caval extension and obstruction.
Medical management of renal vein thrombosis includes aggressive
hydration and anti-coagulation. Nevertheless, prior studies report
conﬂicting data regarding the beneﬁt of anticoagulation with re-
gard to long-term renal function, particularly in cases of bilateral
renal vein thrombosis [14,16]. Thrombolytic therapy may be
considered in cases of bilateral renal vein thrombosis, especially if
there is concomitant renal failure [17]. Surgical thrombectomy for
bilateral renal vein thrombosis with caval involvement and
obstruction has been described once before but with subsequent
unilateral nephrectomy [18].
After failure of systemic anticoagulation and thrombolytic
therapy, with progression of clot burden and impending renal
failure, we made the decision to proceed with operative explora-
tion. The primary goal of surgical therapy was to attempt renal
salvage but in the event that this was not possible, secondary goals
included placement of a peritoneal dialysis catheter and restoration
of IVC continuity in preparation for possible kidney transplant in
the future.
Previous reports of therapy for bilateral renal vein thrombosis
with renal impairment have included optimizing hydration, cor-
recting electrolyte abnormalities, anticoagulation, peritoneal dial-
ysis, and eventual kidney transplant. More recent reports have
demonstrated some success with catheter-directed thrombolysis
[17,19], but this was not attempted in our patient due to her small
size (1.8 kg).
Given the extent of thrombosis in this patient without a
clear etiology, we investigated potential inherited or acquired
causes of thrombophilia. We evaluated for Factor V Leiden (FVL),prothrombin gene 20210A mutation, antiphospholipid antibodies,
lupus anticoagulant, proteins C and S, lipoprotein (a), and homo-
cysteine levels. The patient was found to be a heterozygous carrier
for FVL. FVL, arising from a point mutation in the Factor V gene, is
the most common inherited thrombophilia, occurring in up to 5% of
Caucasians. Factor V is a pro-coagulant protein whose activity is
controlled through cleavage by activated protein C (APC). However
the mutated Factor V Leiden protein is resistant to APC, which
contributes to uninhibited coagulation. Heterozygous carriers have
a 3e5% increased risk of venous thromboembolism [20].
Placental vascular thrombosis is not a rare phenomenon, but it is
sometimes associated with stillbirth or neurologic disability in live
borns [21e26]. In these circumstances, there is often a predisposing
mechanism of mechanical umbilical blood ﬂow restriction, such as
umbilical hypercoiling, abnormal cord insertion, nuchal or body
wrapped cords, and oligohydramnios. In the case reported here, a
marginal umbilical cord insertion was present, providing an
anatomic predisposition to umbilical blood ﬂow restriction. Few
manuscripts address the relationship between placental fetal
vascular thrombosis and renal vein thrombosis [27,28]. If expanded
to include other visceral lesions, manuscripts highlighting placental
fetal vascular thrombosis and cerebral, pulmonary and/or hepatic
thromboemboli/infarction can be added to this relatively short list
[27,29,30]. While some reported cases appear to have been idio-
pathic in origin, predisposing or associated conditions have
included heritable hypercoagulability [28,31] and gestational dia-
betes [32e34]. Our patient demonstrated heterozygosity for the
FVL mutation, which, in concert with a marginal umbilical cord
insertion, may have contributed to both placental and visceral
thrombi.
3. Conclusion
We have shown that neonatal anuric renal failure secondary to
bilateral renal vein and IVC thrombosis can be successfully
managed with early surgical thrombectomy without need for
nephrectomy, thereby avoiding the signiﬁcant morbidity associ-
ated with infant dialysis and renal transplantation. Successful
restoration of renal function after surgical thrombectomy in this
patient illustrates an encouraging treatment option in such severe
cases.
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